lusutrombopag (Mulpleta)
Jump to navigation
Jump to search
Indications
- thrombocytopenia in adults with chronic liver disease scheduled for dental procedure[1]
Contraindications
- breast feeding not recommended
Dosage
Tablets: 3 mg
Adverse effects
Mechanism of action
More general terms
References
- ↑ 1.0 1.1 1.2 FDA Approved Drugs. July 31, 2018 FDA approves lusutrombopag for thrombocytopenia in adults with chronic liver disease. https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm615348.htm
- ↑ HIGHLIGHTS OF PRESCRIBING INFORMATION MULPLETA<TM> (lusutrombopag tablets) for oral use https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/210923s000lbl.pdf